DNLCX
Price
$53.15
Change
+$0.03 (+0.06%)
Updated
Aug 6 closing price
Net Assets
474.47M
VMCPX
Price
$383.79
Change
-$0.20 (-0.05%)
Updated
Aug 6 closing price
Net Assets
196.76B
Interact to see
Advertisement

DNLCX vs VMCPX

Header iconDNLCX vs VMCPX Comparison
Open Charts DNLCX vs VMCPXBanner chart's image
BNY Mellon Active MidCap C
Price$53.15
Change+$0.03 (+0.06%)
VolumeN/A
Net Assets474.47M
Vanguard Mid Cap Index InstitutionalPlus
Price$383.79
Change-$0.20 (-0.05%)
VolumeN/A
Net Assets196.76B
DNLCX vs VMCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNLCX vs. VMCPX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLCX is a StrongBuy and VMCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 197B vs. DNLCX (474M). VMCPX pays higher dividends than DNLCX: VMCPX (1.51) vs DNLCX (0.00). DNLCX was incepted earlier than VMCPX: DNLCX (23 years) vs VMCPX (15 years). DNLCX (2.08) is less costly to investors than VMCPX (0.03). DNLCX is a more actively managed with annual turnover of: 51.78 vs. VMCPX (16.00). DNLCX has a lower initial minimum investment than VMCPX: DNLCX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 18.28 vs. DNLCX (8.05). VMCPX return over 5 years is better than : 62.29 vs. DNLCX (16.39).
DNLCXVMCPXDNLCX / VMCPX
Total Expense Ratio1.750.035,833%
Annual Report Gross Expense Ratio2.080.036,933%
Fund Existence23 years15 years-
Gain YTD4.9807.89863%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets474M197B0%
Annual Yield % from dividends0.001.51-
Returns for 1 year8.0518.2844%
Returns for 3 years15.7131.7350%
Returns for 5 years16.3962.2926%
Returns for 10 years-3.03128.25-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TALK2.410.14
+6.17%
Talkspace
ANEB2.700.06
+2.27%
Anebulo Pharmaceuticals
MANH215.990.22
+0.10%
Manhattan Associates
XENE34.27-0.13
-0.38%
Xenon Pharmaceuticals
GLMD1.45-0.15
-9.37%
Galmed Pharmaceuticals Ltd